*Webinar Recording is currently open access till 31st January 2022.  After this date, the recording will be moved to the CPD platform and restricted to the MABS members only.only.

Unmasking the great imitator. SLE clinical diagnosis and laboratory management.png

Unmasking the Great imitator: SLE
Clinical Diagnosis and Laboratory Management

Assessment

A MABS CPD Certificate will be issued to registrants of the CPD AND on successfully submitting the  questions hereunder.  

Personal Information
Questions

1. In patients with SLE, the serum ANA test is usually 

arrow&v

2. The initial screening dilution in IIF is 

arrow&v

3. A screening test should be

arrow&v

4. Anti-dsDNA antibodies are measured locally using the following technique

arrow&v

5. Which of the following ANA patterns is NOT associated with SLE?

arrow&v

6. Joint inflammation is a characteristic of SLE. The pattern of joint involvement typically involves:​

arrow&v

7. SLE patients may develop a facial “butterfly” rash triggered by:

arrow&v

Your content has been submitted

8. Which of the following is a criterion by the American College of Rheumatology (ACR) for diagnosing SLE:

arrow&v

9. Which serum autoantibody is used to monitor renal disease in SLE (lupus nephritis):

arrow&v

10. Which antimalarial drug is used as first-line treatment in SLE (unless contraindicated):

arrow&v

An error occurred. Try again later

Your content has been submitted